Bradley Merrill Thompson is a shareholder in the national law firm of Epstein Becker & Green, P.C., based out of the firm’s Washington, DC office.  There he counsels software, medical device, and drug companies on a wide range of FDA regulatory issues and leads the firm’s AI practice.

For trade associations, Thompson has served as counsel to AdvaMed and the Continua Health Alliance and as general counsel to the Combination Products Coalition, mHealth Regulatory Coalition, the Clinical Decision Support Coalition, and AI Startups in Health Coalition.

Thompson also serves as Chairman of the Board of EBG Advisors Inc. Affiliated with the law firm, EBG Advisors is a consultancy that takes a multidisciplinary approach to helping healthcare and life sciences companies navigate the obstacles they face.

He served as a member of a workgroup established under the U.S. FDA Safety and Innovation Act to identify key considerations to improve patient safety and promote innovation in health information technology, including mobile medical applications, co-chairing the Regulations Subcommittee.

Thompson has taught food & drug law at Indiana University School of Law-Indianapolis and Columbia Law School.  He also has served as Co-Chair of the Food & Drug Law Committee in the American Bar Association and of the Medical Device Committee of FDLI.

He received his B.A. cum laude, and an M.B.A. from the University of Illinois at Urbana-Champaign and his J.D. cum laude from The University of Michigan Law School.  Thompson also is presently pursuing a Masters in Applied Data Science at the University of Michigan, which he anticipates completing in 2021.